+

WO1990005730A3 - Nouveaux derives de cyclobutane et procede de production - Google Patents

Nouveaux derives de cyclobutane et procede de production Download PDF

Info

Publication number
WO1990005730A3
WO1990005730A3 PCT/JP1989/001190 JP8901190W WO9005730A3 WO 1990005730 A3 WO1990005730 A3 WO 1990005730A3 JP 8901190 W JP8901190 W JP 8901190W WO 9005730 A3 WO9005730 A3 WO 9005730A3
Authority
WO
WIPO (PCT)
Prior art keywords
producing same
cyclobutane derivative
novel
novel cyclobutane
derivative
Prior art date
Application number
PCT/JP1989/001190
Other languages
English (en)
Other versions
WO1990005730A2 (fr
Inventor
Yuh-Ichiro Ichikawa
Aya Narita
Kaoru Matsuo
Keiko Aoyama
Fumiko Matsumura
Yukihiro Nishiyama
Kenichi Matsubara
Takemitsu Nagahata
Hiroo Hoshino
Jun-Ichi Seki
Koichi Narasaka
Yujiro Hayashi
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Priority to DE19893991368 priority Critical patent/DE3991368T1/de
Priority to GB9015942A priority patent/GB2232669B/en
Publication of WO1990005730A2 publication Critical patent/WO1990005730A2/fr
Priority to SE9002445A priority patent/SE501370C2/sv
Publication of WO1990005730A3 publication Critical patent/WO1990005730A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Dérivés de cyclobutane représentés par la formule générale (IV) dans laquelle B représente une base d'acide nucléique et R4 représente un atome d'hydrogène ou un groupe protecteur. On envisage d'employer ces dérivés comme agents antiviraux ou comme agents carcinostatiques.
PCT/JP1989/001190 1988-11-22 1989-11-22 Nouveaux derives de cyclobutane et procede de production WO1990005730A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19893991368 DE3991368T1 (de) 1989-11-22 1989-11-22 Neues cyclobutanderivat und verfahren zu seiner herstellung
GB9015942A GB2232669B (en) 1988-11-22 1989-11-22 Novel cyclobutane derivative and process for producing same
SE9002445A SE501370C2 (sv) 1988-11-22 1990-07-16 Nytt cyklobutanderivat och förfarande för framställning av detsamma

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP63/295135 1988-11-22
JP29513588 1988-11-22
JP1/43036 1989-02-27
JP4303689 1989-02-27
JP15822389 1989-06-22
JP1/158223 1989-06-22

Publications (2)

Publication Number Publication Date
WO1990005730A2 WO1990005730A2 (fr) 1990-05-31
WO1990005730A3 true WO1990005730A3 (fr) 1990-09-07

Family

ID=27291425

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1989/001190 WO1990005730A2 (fr) 1988-11-22 1989-11-22 Nouveaux derives de cyclobutane et procede de production

Country Status (5)

Country Link
ES (1) ES2049678A6 (fr)
GB (1) GB2232669B (fr)
NL (1) NL8921278A (fr)
SE (1) SE501370C2 (fr)
WO (1) WO1990005730A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
EP0159264A2 (fr) * 1984-04-10 1985-10-23 Merck & Co. Inc. Composés antiviraux
EP0184473A1 (fr) * 1984-10-26 1986-06-11 Merck & Co. Inc. Synthèse régiospécifique de dérivés de purine acyclonucléoside 9-substitués
EP0291229A2 (fr) * 1987-05-11 1988-11-17 Merck & Co. Inc. 9(2-(Hydroxyméthyl)cycloalkylméthyl)-guanines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622926B2 (en) * 1988-09-09 1992-04-30 Nippon Kayaku Kabushiki Kaisha Pyrimidine or purine cyclobutane derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
EP0159264A2 (fr) * 1984-04-10 1985-10-23 Merck & Co. Inc. Composés antiviraux
EP0184473A1 (fr) * 1984-10-26 1986-06-11 Merck & Co. Inc. Synthèse régiospécifique de dérivés de purine acyclonucléoside 9-substitués
EP0291229A2 (fr) * 1987-05-11 1988-11-17 Merck & Co. Inc. 9(2-(Hydroxyméthyl)cycloalkylméthyl)-guanines

Also Published As

Publication number Publication date
SE9002445L (sv) 1990-07-16
SE501370C2 (sv) 1995-01-23
WO1990005730A2 (fr) 1990-05-31
GB2232669B (en) 1992-11-25
NL8921278A (nl) 1990-10-01
GB2232669A (en) 1990-12-19
ES2049678A6 (es) 1994-04-16
SE9002445D0 (sv) 1990-07-16
GB9015942D0 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
EP0358154A3 (fr) Dérivé de cyclobutane et procédé pour sa production
CA2003504A1 (fr) Derives de chalcone et methode de preparation
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
CA2011449A1 (fr) 6-epifumagillols, production et utilisation
HUT59675A (en) Process for producing chloro-thiazol derivatives
ATE89559T1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung.
MY104626A (en) A 1-phenylimidazole derivative and its production and use.
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
AU5211686A (en) Pyrazolesulfonamide derivative, process for its production and herbicide containing it
CA2035038A1 (fr) Intermediaires synthetiques de 2-alkynyladenosines, procedes de preparation de ces intermediaires synthetiques, procedes de preparation de 2-alkynyladenosines a l'aide d'intermediaires synthetiques et derives de la 2-alkynyladenosine stable
AU5835190A (en) Antitumor substance be-13793c
EP0277599A3 (fr) Dérivés de cyclopentane contenant du fluor et procédés pour leur préparation
HUP0100453A1 (hu) Eljárás izokarbamidok előállítására
CA2021733A1 (fr) Derive cycloalcanol substitue par un groupe azole, procede pour sa production et son utilisation comme fongicide agricole et horticole
MY110450A (en) Imidazolylmethyl-pyridines, their production their use as pharmaceuticals and pharmaceutical compositions containing them
WO1990005730A3 (fr) Nouveaux derives de cyclobutane et procede de production
ATE61577T1 (de) Fluorierte abkoemmlinge von vitamin-d3 und verfahren zu deren herstellung.
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
ATE102955T1 (de) Zyklisches tetrapeptid und verfahren zu dessen herstellung.
PL290987A1 (en) Method of synthesizing new compounds
PT91011A (pt) Processo para a preparacao de 1 alfa, 3 beta, trihidroxi-esteroides
JPS57131777A (en) Preparation of piperazine derivative
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
AU4243689A (en) Antitumor substance, process for preparing the same and anticancer agent containing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): DE ES GB NL SE

ENP Entry into the national phase in:

Ref document number: 9050027

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 009050027

Country of ref document: ES

Ref document number: P009050027

Country of ref document: ES

AK Designated states

Kind code of ref document: A3

Designated state(s): DE ES GB NL SE

RET De translation (de og part 6b)

Ref document number: 3991368

Country of ref document: DE

Date of ref document: 19910110

WWE Wipo information: entry into national phase

Ref document number: 3991368

Country of ref document: DE

WWG Wipo information: grant in national office

Ref document number: 9050027

Country of ref document: ES

Kind code of ref document: A

WWX Former pct application expired in national office

Ref document number: 9050027

Country of ref document: ES

Kind code of ref document: A

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载